-65%

est. 2Y upside i

HealthcareSeries D+

Watsi is the first global crowdfunding platform for medical…

Rank

#3447

Sector

Healthcare Crowdfunding

Est. Liquidity

~5Y

Data Quality

Data: Low

Watsi's equity is likely to have negligible value.

Last updated: July 3, 2026

Bull (5%)+10%

Acquisition by a large healthcare NGO or philanthropist at a modest premium to current revenue (e.g., 5x). Assumes entry valuation of ~$10M, exit ~$11.65M, but after preference common recovers ~10%.

Base (30%)-50%

Revenue stagnates, no liquidity event; equity value remains at preference overhang. Common stock worth zero after 1x preference liquidation, implying -100% from entry, but after dilution adjustment -50%.

Bear (65%)-100%

No exit; company continues as perpetual non-profit with no equity value. Preference stack consumes all proceeds. Common stock recovers -100%.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

21200%

Total funding of $4.82M exceeds any realistic entry valuation, creating 1x preference overhang that wipes out common equity.

Dilution Risk

high

Likely need to raise within 24 months given 2015 round; dilution expected to be 20% or more.

Secondary Liquidity

none

No secondary market exists for a non-profit's equity.

Questions to Ask at the Interview

Strategic questions based on Watsi's data — designed to show you've done your homework.

  • 1

    “How does Watsi plan to increase revenue growth from 1.4% to double digits?”

  • 2

    “What is the long-term liquidity plan for equity holders given the non-profit status?”

  • 3

    “How does the company's 501(c)(3) status affect equity compensation structure?”

Community

Valuation Sentiment

Our model estimates -65% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.